Skip to content
Peptide research

NA-Semax Amidate

Also known as N-Acetyl Semax Amidate · Acetylated Semax
Category
Brain & Cognition
Administration routes
Nasal
Regulatory status
Not FDA-approved

What it is

A stabilized, injectable analog of Semax marketed for focus, cognitive enhancement, and stroke neuroprotection. Its best support comes from stroke recovery (improved outcomes with elevated BDNF), but claims about blood flow, brain connectivity, and memory gains rest on thin human data or mechanism studies alone. Safety data on this NA-Amidate form is essentially absent. Not an approved drug in the US; supply is largely unregulated research-grade peptide.

Read Full record

Studied uses & evidence

Studied uses(6)

  • Neuroprotection in stroke — improved outcomes and elevated BDNF in clinical use

    Medium

    Small, unblinded human trials in stroke patients reported faster recovery and raised BDNF.

  • Increased BDNF and NGF expression in hippocampus and frontal cortex

    Medium

    Extensive animal data, mostly one research lineage, with supportive human plasma BDNF findings.

  • Default mode network changes reported with parent Semax; benefit for NA-Semax Amidate is unestablished

    Speculative

    DMN connectivity shifts were shown for parent compound Semax, not tested directly in NA-Semax Amidate.

Evidence limits

Evidence Level
Very Limited Evidence

Semax has been used clinically in Russia for over two decades for stroke, TBI, and cognitive disorders. However, most clinical data is published in Russian-language journals with limited English translations. Key clinical findings include improved neurological outcomes in stroke patients (n=110) and increased BDNF levels. An fMRI study in healthy subjects showed neural connectivity changes with intranasal Semax. The ADDF notes that 'published literature of well-conducted studies is lacking' in English. NA-Semax Amidate has not been tested in clinical trials.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(3)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Limited safety data on the specific NA-Amidate form

    High
  • Potential serotonergic and dopaminergic effects

    Low
  • Methionine oxidation (specific to Semax/NA-Semax)

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.